ALTANA Pharma

Cities in Germany

0 studies enrolling now · 1 studies all time

What they study most

COPD, Chronic Obstructive Pulmonary Disease

Studies at this site

• OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111) — Completed